Overview:Advances in Biology and Therapy of Multiple Myeloma - Despite the advances in conventional, novel agent and high dose chemotherapy multiple myeloma (MM) remains incurable. In order to overcome resistance to current therapies and improve patient outcome, novel biologically-based treatment approaches are being developed. Current translational research in MM focusing on the development of molecularly-based combination therapies has great promise to achieve high frequency and durable responses in the majority of patients. Two major advances are making this goal possible. First, recent advances in genomics and proteomics in MM have allowed for increased understanding of disease pathogenesis, identified novel therapeutic targets, allowed for molecular classification, and provided the scientific rationale for combining targeted therapies to increase tumor cell cytotoxicity and abrogate drug resistance. Second, there is now an increased understanding of how adhesion of MM cells in bone marrow (BM) further impacts gene expression in MM cells, as well as in BM stromal cells (BMSCs). As a result of these advances in oncogenomics on the one hand and increased understanding of the role of the BM in the pathogenesis of MM on the other, a new treatment paradigm targeting the tumor cell and its BM microenvironment to overcome drug resistance and improve patient outcome has now been developed. Thalidomide, lenalidomide, and Bortezomib are three agents which target the tumor cell in its microenvironment in both laboratory and animal models and which have rapidly translated from the bench to the bedside. Ongoing efforts are using oncogenomics and cell signaling studies to identify next generation of therapies in MM on the one hand, and to inform the design of combination trials on the other. This new paradigm for overcoming drug resistance and improving patient outcome in MM has great promise not only to change the natural history of MM, but also to serve as a model for targeted therapeutics directed to improve outcome of patients with MM.
This book is on page /c4d1fa1948753c78ba2536910f976327/book/1603729762-9781461460916. It was written by the following authors: Kenneth C. Anderson, Nikhil C. Munshi. Book Advances in Biology and Therapy of Multiple Myeloma, which can be read online, published by the company: Springer-Verlag New York Inc.. Other books on similar topics can be found in sections: Science, Technology, Medicine. The book was published on 2012-12-19 00:00:00. It has 530 pages and is published in Hardback format and weight g. File for download Advances in Biology and Therapy of Multiple Myeloma has PDF format and is called advances-in-biology-and-therapy-of-multiple-myeloma.pdf. Other books you can download below. Our bisontinesbisontins.fr site is not responsible for the content of PDF files.
How to download book Advances in Biology and Therapy of Multiple Myeloma?
1. Select the button you need.
2. Go to the file view page.
3. The link to the file will be available if you are logged into your account.
4. If you don't have an account, click Subscribe.
5. Enjoy your favorite book.